{"DataElement":{"publicId":"7351529","version":"1","preferredName":"Biospecimen Findings Supplemental Qualifiers Dataset Fluorescence In Situ Hybridization Chromosome 17 Assessment Status","preferredDefinition":"The results of Fluorescence in Situ Hybridization testing for Chromosome 17 (BRAF) mutation(s).","longName":"SUPPBS_QVAL_BSORRES_BRAFFISH","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7351510","version":"1","preferredName":"Biospecimen Findings Supplemental Qualifiers Dataset Fluorescence In Situ Hybridization Chromosome 17 Assessment Outcome","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the biospecimen findings domain._A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping._The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells._The final result of a determination of the value, significance, or extent of._The result of an action.","longName":"7385447v1.0:7351508v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"7385447","version":"1","preferredName":"Biospecimen Findings Supplemental Qualifiers Dataset","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the biospecimen findings domain.","longName":"C147189","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen Findings Supplemental Qualifiers Dataset","conceptCode":"C147189","definition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the biospecimen findings domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC8E5030-50CE-0686-E053-4EBD850A485C","latestVersionIndicator":"Yes","beginDate":"2020-08-10","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-08-10","modifiedBy":"ONEDATA","dateModified":"2020-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7351508","version":"1","preferredName":"Fluorescence in Situ Hybridization Chromosome 17 Assessment Outcome","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.:The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.:The final result of a determination of the value, significance, or extent of.:The result of an action.","longName":"C17563:C13212:C25217:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Human Chromosome 17","conceptCode":"C13212","definition":"The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA564E6A-9030-5A1D-E053-4EBD850AE182","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA564E6A-9041-5A1D-E053-4EBD850AE182","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-13","modifiedBy":"SPRINGERL","dateModified":"2020-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7348730","version":"1","preferredName":"Fluorescence In Situ Hybridization Assessment Status","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping._The final result of a determination of the value, significance, or extent of._A condition or state at a particular time.","longName":"7348730v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"4494160","version":"1","preferredName":"Normal","longName":"4494160","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"043C792C-06A7-5C4A-E050-BB89AD433FD8","latestVersionIndicator":"Yes","beginDate":"2014-09-29","endDate":null,"createdBy":"RODGERSC","dateCreated":"2014-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B9BD4B-3508-4056-E053-4EBD850A9B6B","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"ER or PgR postitive","valueDescription":"Estrogen Receptor Or Progesterone Receptor Positive","ValueMeaning":{"publicId":"7348731","version":"1","preferredName":"Estrogen Receptor Or Progesterone Receptor Positive","longName":"7348731","preferredDefinition":"Estrogen receptor (595 aa, ~66 kDa) is encoded by the human ESR1 gene. This protein plays a role in the regulation of estradiol-dependent gene transcription.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.: Involving advantage or good.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor","conceptCode":"C38361","definition":"Estrogen receptor (595 aa, ~66 kDa) is encoded by the human ESR1 gene. This protein plays a role in the regulation of estradiol-dependent gene transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Progesterone Receptor","conceptCode":"C17075","definition":"Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9B9D95D-BEE5-3DB6-E053-4EBD850A4039","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B9D95D-BEFE-3DB6-E053-4EBD850A4039","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"ER and PgR postitive","valueDescription":"Estrogen Receptor And Progesterone Receptor Positive","ValueMeaning":{"publicId":"7348732","version":"1","preferredName":"Estrogen Receptor And Progesterone Receptor Positive","longName":"7348732","preferredDefinition":"Estrogen receptor (595 aa, ~66 kDa) is encoded by the human ESR1 gene. This protein plays a role in the regulation of estradiol-dependent gene transcription.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.: Involving advantage or good.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor","conceptCode":"C38361","definition":"Estrogen receptor (595 aa, ~66 kDa) is encoded by the human ESR1 gene. This protein plays a role in the regulation of estradiol-dependent gene transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Progesterone Receptor","conceptCode":"C17075","definition":"Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9B9D95D-BF0D-3DB6-E053-4EBD850A4039","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B9D95D-BF26-3DB6-E053-4EBD850A4039","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"ER and PgR negative","valueDescription":"Estrogen Receptor And Progesterone Receptor Negative","ValueMeaning":{"publicId":"7348733","version":"1","preferredName":"Estrogen Receptor And Progesterone Receptor Negative","longName":"7348733","preferredDefinition":"Estrogen receptor (595 aa, ~66 kDa) is encoded by the human ESR1 gene. This protein plays a role in the regulation of estradiol-dependent gene transcription.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.: Involving disadvantage or harm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor","conceptCode":"C38361","definition":"Estrogen receptor (595 aa, ~66 kDa) is encoded by the human ESR1 gene. This protein plays a role in the regulation of estradiol-dependent gene transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Progesterone Receptor","conceptCode":"C17075","definition":"Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9B9D95D-BF35-3DB6-E053-4EBD850A4039","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B9D95D-BF4E-3DB6-E053-4EBD850A4039","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Positive for 3 BRAF duplication","valueDescription":"Positive For BRAF Gene Gene Duplication Abnormality","ValueMeaning":{"publicId":"7348734","version":"1","preferredName":"Positive For BRAF Gene Gene Duplication Abnormality","longName":"7348734","preferredDefinition":"Involving advantage or good.: The reason of something.: This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.: Generation of an extra copy of a particular gene in the genome. A gene duplication abnormality may occur by gene amplification, random breakage and reunion, retrotransposition or unequal crossing-over at meiosis. A gene duplication abnormality can be either heritable or somatic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"BRAF Gene","conceptCode":"C18363","definition":"This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Duplication Abnormality","conceptCode":"C45582","definition":"Generation of an extra copy of a particular gene in the genome. A gene duplication abnormality may occur by gene amplification, random breakage and reunion, retrotransposition or unequal crossing-over at meiosis. A gene duplication abnormality can be either heritable or somatic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9B9D95D-BF5D-3DB6-E053-4EBD850A4039","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B9D95D-BF76-3DB6-E053-4EBD850A4039","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Negative for 3 BRAF duplication","valueDescription":"Negative For BRAF Gene Gene Duplication Abnormality","ValueMeaning":{"publicId":"7348735","version":"1","preferredName":"Negative For BRAF Gene Gene Duplication Abnormality","longName":"7348735","preferredDefinition":"Involving disadvantage or harm.: The reason of something.: This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.: Generation of an extra copy of a particular gene in the genome. A gene duplication abnormality may occur by gene amplification, random breakage and reunion, retrotransposition or unequal crossing-over at meiosis. A gene duplication abnormality can be either heritable or somatic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"BRAF Gene","conceptCode":"C18363","definition":"This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Duplication Abnormality","conceptCode":"C45582","definition":"Generation of an extra copy of a particular gene in the genome. A gene duplication abnormality may occur by gene amplification, random breakage and reunion, retrotransposition or unequal crossing-over at meiosis. A gene duplication abnormality can be either heritable or somatic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9B9D95D-BF85-3DB6-E053-4EBD850A4039","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B9D95D-BF9E-3DB6-E053-4EBD850A4039","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Abnormal","valueDescription":"Abnormal","ValueMeaning":{"publicId":"2570062","version":"1","preferredName":"Abnormal","longName":"2570062","preferredDefinition":"Deviating from the norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DEBB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"COOPERM","dateModified":"2008-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B86001-1E37-3E3F-E053-4EBD850AF53A","beginDate":"2015-07-07","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B86001-1E5F-3E3F-E053-4EBD850AF53A","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative","ValueMeaning":{"publicId":"2559499","version":"1","preferredName":"Negative","longName":"2559499","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B578-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B86001-1E69-3E3F-E053-4EBD850AF53A","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"2568055","version":"1","preferredName":"Not Done","longName":"2568055","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"REEVESD","dateModified":"2014-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B86001-1E87-3E3F-E053-4EBD850AF53A","beginDate":"2007-08-09","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B86001-1E91-3E3F-E053-4EBD850AF53A","beginDate":"2019-04-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive","ValueMeaning":{"publicId":"2559831","version":"1","preferredName":"Positive","longName":"2559831","preferredDefinition":"Involving advantage or good.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6C4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B86001-1E9B-3E3F-E053-4EBD850AF53A","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7349844","version":"1","preferredName":"Fluorescence in Situ Hybridization Assessment Status","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.:The final result of a determination of the value, significance, or extent of.:A condition or state at a particular time.","longName":"C17563:C25217:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9EF2B3C-A5FC-0C9E-E053-4EBD850A414A","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9B86001-1E1F-3E3F-E053-4EBD850AF53A","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"SPRINGERL","dateModified":"2020-09-21","changeDescription":"ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Result of FISH for BRAF dupli","type":"Preferred Question Text","description":"Result of FISH for BRAF duplication:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA569391-C743-5C1F-E053-4EBD850AF3F9","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-13","modifiedBy":"SPRINGERL","dateModified":"2020-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}